“…The importance of the human microbiome has been increasingly recognized in biomedicine, due to its association with many complex diseases, such as obesity (Turnbaugh et al, 2009), cardiovascular disease (Koeth et al, 2013), diabetes (Qin et al, 2012;Dobra et al, 2019;Ren et al, 2020), liver cirrhosis (Qin et al, 2014), inflammatory bowel disease (Halfvarson et al, 2017), psoriasis (Tett et al, 2017), and colorectal cancer (Zackular et al, 2016), and its response to cancer immunotherapy (Frankel et al, 2017;Gopalakrishnan et al, 2018;Zitvogel et al, 2018). Advances in high-throughput next generation sequencing technologies (e.g., 16S ribosomal RNA [rRNA] sequencing, shotgun sequencing) make it possible to fully characterize the human microbiome, better understand the risk factors (e.g., clinical, genetic, environmental) that shape the human microbiome, and decipher the function and impact of the microbiome profile on human health and diseases (Li, 2015;Chen and Li, 2016;Zhu et al, 2017;Zhang et al, 2018;Reyes-Gibby et al, 2020;Sun et al, 2020;Wang et al, 2020b).…”